Trisomy of the Long Arm of Chromosome 1 Resulting in a Dicentric Derivative (6)t(1;6) Chromosome in a Child with Myelodysplastic Syndrome Following Treatment for a Primitive Neuroectodermal Tumor

References

• List A.F., Jacobs A. Biology and pathogenesis of the myelodysplastic syndromes. Seminars in Oncology 1992; 19: 14–24
   PubMed Web of Science ®Google Scholar
• Sawada K. Impaired proliferation and differentiation of myelodysplastic CD34+ cells. Leukemia and Lymphoma 1994; 14: 37–47
   PubMed Web of Science ®Google Scholar
• Hasle H., Kerndrup G., Jacobsen B.B. Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions. Leukemia 1995; 9: 1569–1572
   PubMed Web of Science ®Google Scholar
• Jackson G.H., Carey P.H., Cant A.J., Brown N.P., Reid M.M. Myelodysplastic syndrome in childhood [letter]. British Journal of Hematology 1993; 84: 185–186
   PubMed Web of Science ®Google Scholar
• Hasle H., Schultz K.R., Wadsworth L.D., Massing B.G., McBride M. Population based study of childhood myelodysplastic syndrome in British Columbia, Canada. Blood 1998; 92: 629a, #2594
   Web of Science ®Google Scholar
• Jacobs R.H., Cornbleet M.A., Vardiman J.W., Larson R.A., Le Beau M.M., Rowley J. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 1986; 67: 1765–1772
   PubMed Web of Science ®Google Scholar
• Yunis J.J., Rydell R.E., Oken M.M., Arnesen M.A., Mayer M.G., Lobell M. Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 1986; 67: 1721–1730
   PubMed Web of Science ®Google Scholar
• Johansson B., Mertens F., Mitelman F. Cytogenetic deletion maps of hematological neoplasms: circumstantial evidence for tumor suppressor loci. Genes Chromosomes and Cancer 1993; 8: 205–218
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard J., Philip P., Tinggaard P.N., Hou-Jensen K., Svejaard A., Jensen G., Nissen N.I. Acute non-lymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients. Cancer 1984; 54: 452–462
   PubMed Web of Science ®Google Scholar
• Scheres J. M. J. C., Hustinx T.W.J., Holdrinet R.S.G., Geraedts J.P.M., Hagemeijer A., van der Blij-Philipsen M. Translocation 1;7 in dyshematopoiesis: possibly induced with a nonrandom geographic distribution. Cancer Genetics and Cytogenetics 1984; 12: 283–294
   PubMed Web of Science ®Google Scholar
• Scheres J. M. J. C., Hustinx T.W.J., Geraedts J.P.M., Leeksma C.H.W., Meltzer P.S. Translocation 1;7 in hematologic disorders: A brief review of 22 cases. Cancer Genetics and Cytogenetics 1985; 18: 207–213
   PubMed Web of Science ®Google Scholar
• Morrison-DeLap S.J., Kuffel D.G., Dewald G.W., Letendre L. Unbalanced 1;7 translocation and therapy-induced hematologic disorder: A possible relationship. American Journal of Hematology 1986; 21: 39–47
   PubMed Web of Science ®Google Scholar
• Lai J.L., Fenaux P., Savary J.B., Jouet J.P., Le Pelley P., Bauters F., Deminatti M. Translocation (1;7) in a case of secondary chronic myelomonocytic leukemia. Cancer Genetics and Cytogenetics 1987; 24: 355–357
   PubMed Web of Science ®Google Scholar
• Bseiso A.W., Kantarjian H., Estey E. Myelodysplastic syndrome following successful therapy of acute promyelocytic leukemia. Leukemia 1997; 11: 168–169
   PubMed Web of Science ®Google Scholar
• Andersen M.K., Johansson B., Larson S.O., Pedersen-Bjergaard J. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements. Hematologica 1998; 83: 483–488
   PubMed Web of Science ®Google Scholar
• Third MIC Cooperative Study Group. Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders. Cancer Genetics Cytogenetics 1988; 32: 1–10
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard J., Anderson M.K. Secondary or therapy related MDS and AML and their chromosome aberrations. Important to study but difficult to establish causality. Hematologica 1998; 83: 481–482
   PubMedGoogle Scholar
• Moir D.J., Jones P.A.E., Pearson J., Duncan J.R., Cook P., Buckle V.J. A new translocation t(1;3)(p36;q21) in myelodysplastic disorders. Blood 1984; 64: 553–555
   PubMed Web of Science ®Google Scholar
• Mitelman F. Catalog of chromosome aberrations in cancer. Wiley-Liss, New York 1995
   Google Scholar
• Horiike S., Taniwaki M., Misawa S., Abe T. Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer 1988; 62: 1129–1138
   PubMed Web of Science ®Google Scholar
• Horsman D.E., Massing B.G., Chan K.W., Kalousek D.K. Unbalanced translocation (1;7) in childhood myelodysplasia. American J Hematology 1988; 27: 174–178
   PubMed Web of Science ®Google Scholar
• Mascarello J.T., Osborn C., Kadota R.P. A dysmorphic child with myelodysplasia characterized by a duplication of 1q and multiple duplication of 3q. Cancer Genetics and Cytogenetics 1989; 38: 9–12
   PubMed Web of Science ®Google Scholar
• Fonatsch C., Haase D., Freund M., Bartels H., Tesch H. Partial trisomy 1q. A nonrandom primary chromosomal abnormality in myelodysplastic syndromes?. Cancer Genetics and Cytogenetics 1991; 56: 243–253
   PubMed Web of Science ®Google Scholar
• Privitera E., Wang W., Raimondi S.C. Monosomy 7 and unbalanced t(1;7) in an adolescent boy with myelodysplastic syndrome. Leukemia 1992; 6: 742–745
   PubMed Web of Science ®Google Scholar
• Marina N.M., Pappo A.S., Parham D.M., Cain A.M., Rao B.N., Poquette C.A., Pratt C.B., Greenwald C., Meyer W.H. Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round cell tumors: a feasibility study at St. Jude Children's Research Hospital. Journal of Clinical Oncology 1999; 17: 180–190
   PubMed Web of Science ®Google Scholar
• Atkin N.B. Chromosome 1 aberrations in cancer. Cancer Genetics and Cytogenetics 1986; 21: 279–285
   PubMed Web of Science ®Google Scholar
• Olah E., Balogh E., Kovacs I., Kiss A. Abnormalities of chromosome 1 in relation to human malignant diseases. Cancer Genetics and Cytogenetics 1989; 43: 179–194
   PubMed Web of Science ®Google Scholar
• Morris C.M., Fitzgerald P.H., Neville M.A., Wyld P.J., Beard M.E.J. Does multisomy of chromosome 1q confer a proliferative advantage in B-cell acute lymphoblastic leukemia?. Cancer 1984; 54: 48–53
   PubMed Web of Science ®Google Scholar
• Gagos S., Hopwood V.L., Iliopoulos D., Kostakis A., Karayannakos P., Yatzides H., Skalkeas G.D., Pathak S. Chromosomal markers associated with metastasis in two colon cancer cell lines established from the same patient. Anticancer Research 1995; 15: 369–378
   PubMed Web of Science ®Google Scholar
• Gronwald J., Storkel S., Holtgreve-Grez H., Hadaczek P., Brinkschmidt C., Jauch A., Lubinski J., Cremer T. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: Importance of 1q and 3p copy number changes in metastatic events. Cancer Research 1997; 57: 481–487
   PubMed Web of Science ®Google Scholar
• Huret J.L., Tanzer J., Guilhot F., Frocrain-Herchkovitch C., Savage J.R.K. Karyotype evolution in the bone marrow of a patient with Fanconi anemia: breakpoints in clonal anomalies of this disease. Cytogenetics and Cell Genetics 1988; 48: 224–221
   PubMedGoogle Scholar
• Groupe Francais de Cytogenetique Hematologique. Cytogenetics of acutely transformed chronic myeloproliferative syndromes without a Philadelphia chromosome. A multicenter study of 55 patients. Cancer Genetics and Cytogenetics 1988; 32: 157–168
   PubMed Web of Science ®Google Scholar
• Mecucci C., Michaux J.L., Louwagie A., Boogaerts M., Van den Berghe H. The short arm of chromosome 6 is nonrandomly rearranged in secondary myelodysplastic syndromes. Cancer Genetics and Cytogenetics 1988; 31: 147–155
   PubMed Web of Science ®Google Scholar
• Sawyer J.R., Tricot G., Mattox S., Jagannath S., Barlogie B. Jumping translocations of chromosome 1q in multiple myeloma: Evidence for a mechanism involving decondensation of pericentromeric heterochromatin. Blood 1998; 91: 1732–1741
   PubMed Web of Science ®Google Scholar
• Almeida A., Kokalj-Vokac N., Lefrancois D., Viegas-Pequignot E., Jeanpierre M., Dutrillaux B., Malfoy B. Hypomethylation of classic satellite DNA and chromosome instability in lymphoblastoid cell lines. Human Genetics 1993; 91: 538–546
   PubMed Web of Science ®Google Scholar
• Fitzgerald P.H., Morris C.M. Telomeric association of chromosomes in B-cell lymphoid leukemia. Human Genetics 1984; 67: 385–390
   PubMed Web of Science ®Google Scholar
• Hartwell L.H., Kastan M.B. Cell cycle control and cancer. Science 1994; 266: 1821–1828
   PubMed Web of Science ®Google Scholar
• Schmid M., Grunert D., Haaf T., Engel W. Direct demonstration of somatically paired heterochromatin of human chromosomes. Cytogenetics and Cell Genetics 1983; 63: 544–561
   Google Scholar
• Kokalj-Vokac N., Almeida A., Viegas-Pequingnot E., Jeanpierre M., Malfoy B., Dutrillaux B. Specific induction of uncoiling and recombination by azacytidine in classical satellite-containing constitutive heterochromatin. Cytogenetics and Cell Genetics 1993; 63: 11–15
   PubMedGoogle Scholar
• Raimondi S.C., Mathew S., Pui C-H. Cytogenetics as a diagnostic aid for childhood hematological disorders. Conventional cytogenetic techniques, Fluorescence in situ hybridization, and comparative genomic hybridization. Methods in Molecular Medicine Vol: 14: Tumor Marker protocols, M. Hanausek, A. Walaszek. Humana Press, Totowa, NJ 1997; 209–227
   Google Scholar
• ISCN, Mitelman F. An International System for Human Cytogenetic Nomenclature. S. Karger, Basel 1995
   Google Scholar